imiquimod has been researched along with Experimental Mammary Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Li, S; Liu, YJ; Qiao, Y; Wu, J; Yang, Y; Zhang, M; Zhu, S | 1 |
| Amon, LM; Chang, A; Disis, ML; Duan, H; Gad, E; Larson, ER; Lu, H; Tufvesson, H; Van Denend, N; Wagner, WM; Yang, Y | 1 |
| Adams, S; Babb, JS; Demaria, S; Dewan, MZ; DiNapoli, S; Formenti, SC; Kawashima, N; Vanpouille-Box, C | 1 |
| Kohrt, H | 1 |
| Donnini, A; Orlando, F; Papalini, F; Provinciali, M; Re, F; Smorlesi, A | 1 |
| Dominguez, AL; Hoelzinger, DB; Lustgarten, J; Sharma, S | 1 |
6 other study(ies) available for imiquimod and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
TLR-activated plasmacytoid dendritic cells inhibit breast cancer cell growth in vitro and in vivo.
Topics: Aminoquinolines; Animals; Dendritic Cells; Disease Models, Animal; Female; Granzymes; Imiquimod; Immunotherapy, Adoptive; Interferon Inducers; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; TNF-Related Apoptosis-Inducing Ligand; Toll-Like Receptor 7; Toll-Like Receptor 9 | 2017 |
Treatment failure of a TLR-7 agonist occurs due to self-regulation of acute inflammation and can be overcome by IL-10 blockade.
Topics: Acute Disease; Administration, Topical; Aminoquinolines; Animals; CD8-Positive T-Lymphocytes; Growth Inhibitors; Imiquimod; Inflammation Mediators; Interleukin-10; Ligands; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Mice; Mice, Transgenic; Neoplasm Invasiveness; Random Allocation; Receptor, ErbB-2; Toll-Like Receptor 7; Treatment Failure; Up-Regulation | 2010 |
Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancer.
Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chemoradiotherapy; Cyclophosphamide; Cytokines; Dose Fractionation, Radiation; Drug Synergism; Histocompatibility Antigens Class I; Humans; Imiquimod; Immunologic Memory; Injections, Intraperitoneal; Intercellular Adhesion Molecule-1; Lymph Nodes; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Neoplasm Recurrence, Local; Neoplasm Transplantation; Skin Neoplasms; T-Lymphocytes; Toll-Like Receptor 7; Tumor Burden | 2012 |
Breast cancer treatment with imiquimod: applying an old lotion to a new disease.
Topics: Aminoquinolines; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Imiquimod; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Skin Neoplasms; Toll-Like Receptor 7 | 2012 |
Imiquimod and S-27609 as adjuvants of DNA vaccination in a transgenic murine model of HER2/neu-positive mammary carcinoma.
Topics: Adjuvants, Immunologic; Adoptive Transfer; Aminoquinolines; Animals; Cancer Vaccines; Female; Genes, erbB-2; Genetic Therapy; Imiquimod; Interferon-gamma; Interleukin-10; Interleukin-2; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Models, Animal; Vaccines, DNA | 2005 |
CpG-ODN but not other TLR-ligands restore the antitumor responses in old mice: the implications for vaccinations in the aged.
Topics: Adjuvants, Immunologic; Aging; Aminoquinolines; Animals; Antigen-Presenting Cells; Cytokines; Flagellin; Flow Cytometry; Imiquimod; Ligands; Lipopolysaccharides; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oligodeoxyribonucleotides; Poly I-C; T-Lymphocytes; Toll-Like Receptors; Vaccination | 2008 |